Regulatory CD4+ T cells (Treg) and cytotoxic CD8+ T cells have emerged as the dominant effectors in host myeloma control in syngeneic transplantable murine myeloma models (2, 3) underpinning autologous graft versus myeloma as an important process in disease control (4). The gene discussed is CD8A; the disease is plasma cell myeloma.